Selleckchem Inc

Bio Active Compounds.

Recent products

Anti-KAAG1 (ADCT-901-MMAE)

Price range: £794.00 through £6,527.00 / 1,111.609,137.80 Standard

Anti-GPC3 / Glypican-3 (Codrituzumab-MMAE)

Price range: £794.00 through £6,527.00 / 1,111.609,137.80 Standard

Mirvetuximab-MMAE

Price range: £794.00 through £6,527.00 / 1,111.609,137.80 Standard

IMGN779

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Ladiratuzumab vedotin

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Glembatumumab vedotin

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Enfortumab vedotin-ejfv

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Trastuzumab MMAE

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Tisotumab vedotin

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Datopotamab deruxtecan

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Disitamab vedotin

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Labetuzumab govitecan

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Telisotuzumab vedotin

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Brentuximab vedotin

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Depatuxizumab mafodotin

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Praluzatamab ravtansine

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

1 646 647 648 705